In this episode of She Leads Biotech, I’m joined by Deanna Angello, a seasoned commercial leader whose career spans some of the biggest names in healthcare: Pfizer, Kite Pharma, J&J, and Genentech.
But this isn’t just a highlight reel of commercial success. It’s a conversation about what happens when life interrupts the script — and how that moment can bring clarity, courage, and an entirely new sense of purpose.
We talk about:
Navigating career grief after personal loss
How Genentech prepared her for some of the most high-stakes commercial threats in biotech
Why FDA approval is only the beginning — not the end — of access
Building scalable systems that serve both patients and teams
What she's looking for in her next chapter as a Chief Commercial Officer
If you're building something big — and looking for someone who’s done it all but still thinks like a builder — you’ll want to hear this one.
📌 Chapters / Timestamps
00:00 – Meet Deanna Angello
02:00 – From Pfizer to Genentech: early lessons and leadership
06:00 – Grief, clarity, and stepping off the treadmill
10:00 – Building commercial systems that last
14:00 – Patient access and the real work after FDA approval
18:30 – What she’s looking for in her next CCO role
23:00 – Advice for leaders ready to rethink their own path
#SheLeadsBiotech #DeannaAngello #BiotechLeadership #WomenInSTEM #ChiefCommercialOfficer #LifeSciences #PatientAccess #AuthenticLeadership #CareerPivot #CNAInternationalUSA
